Sichuan Kangcheng Biotechnology is a pre-clinical drug discovery contract research organization (CRO) located in the prosperous and time-honored city of Chengdu in Southwestern China. Founded and affiliated with Sichuan University West China Hospital, Kangcheng continues to develop innovative animal disease models ranging from rodents to non-human primates，including Cardiovascular diseases, CNS diseases, oncology, metabolic diseases, Ophthalmic diseases, Autoimmune diseases, Liver and Kidney diseases. We are particularly strong on minimally-invasive catheterization for cardio-cerebral vascular diseases, patient-derived xenograft models, molecular imaging, neurological studies augmented with automated behavioral assessment, dynamic CSF sampling from cisterna magna and gut microbiome studies. With a highly professional team, state-of-the-art equipment, and AAALAC-accredited animal facilities, we provide standard or customized preclinical screening or efficacy evaluation services to our domestic and international customers.  We have helped many clients win IND approval in both China and USA.